Skip to main content
. 2000 Oct 15;6(5):647–650. doi: 10.3748/wjg.v6.i5.647

Table 1.

The number and size of γ-GT positive hepatocyte-group (x- ± sx-)

Group Treatment No./cm2 mm2/cm2 mm2/No.
A Normal control 167.29 ± 50.47 2.90 ± 1.01 0.017 ± 0.002
B AFB1 71.92 ± 42.19a 1.14 ± 0.69a 0.015 ± 0.002
C AFB1 + OLT daily 167.10 ± 45.94cd 2.73 ± 0.87cd 0.016 ± 0.001
D AFB1 + OLT weekly 83.66 ± 34.94a 1.33 ± 0.86a 0.015 ± 0.002b

t test:

a

P < 0.05,

b

P < 0.01, vs group A;

c

P < 0.01, vs group B;

d

P < 0.01, vs group D. OLT: Oltipraz; No./cm2: The number of γ-GT positive hepatocyte-group per cm2 of liver tissue; mm2/cm2: mm2 of γ-GT positive hepatocyte-group per cm2 of liver tissue; mm2/No.: mm2 of γ-GT positive hepatocyte-group per each one.